(₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 1573.96 | 1587.77 | 1451.26 | -0.9% | 8.5% |
Total Expenses | 1517.36 | 1539.99 | 1431.30 | -1.5% | 6.0% |
Profit Before Tax | 56.60 | 47.78 | 19.96 | 18.5% | 183.6% |
Tax | 10.73 | 9.08 | 6.26 | 18.2% | 71.4% |
Profit After Tax | 45.87 | 38.70 | 13.71 | 18.5% | 234.6% |
Earnings Per Share | 3.80 | 3.20 | 1.10 | 18.7% | 245.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Medplus Health Services Ltd is a prominent company in the healthcare sector, primarily engaged in the distribution and retail of pharmaceutical products. It operates as a pharmacy retail chain, offering a wide range of prescription and over-the-counter medications, along with wellness and personal care products. The company is known for its extensive network of stores and its focus on providing accessible healthcare solutions across various regions. While specific details about recent major developments are not provided, the company is expected to continue expanding its presence in the healthcare industry.
For the quarter ended Q3FY25, Medplus Health Services Ltd reported a total income of ₹1573.96 crores. This represents a slight decrease of 0.9% compared to the previous quarter, Q2FY25. However, when examining the year-over-year performance, there is a notable increase of 8.5% from Q3FY24, where total income was ₹1451.26 crores. This growth in total income over the year highlights the company's capability to enhance its revenue generation despite a minor dip in the quarter-over-quarter analysis.
The financial data for Q3FY25 indicates a profit before tax of ₹56.60 crores, which marks an 18.5% increase compared to the preceding quarter, Q2FY25. More significantly, there is a substantial year-over-year increase of 183.6% from Q3FY24's profit before tax of ₹19.96 crores. The company incurred a tax expense of ₹10.73 crores in Q3FY25, showing an 18.2% rise from Q2FY25 and a 71.4% increase from the same quarter last year. Consequently, the profit after tax stood at ₹45.87 crores, reflecting an 18.5% increase QoQ and an impressive 234.6% increase YoY. Earnings per share for Q3FY25 were ₹3.80, marking an 18.7% rise from the previous quarter and a 245.5% increase from Q3FY24.
Medplus Health Services Ltd's total expenses for Q3FY25 amounted to ₹1517.36 crores, which is a 1.5% decrease from Q2FY25. On a year-over-year basis, total expenses increased by 6.0% from Q3FY24. This reduction in expenses from the previous quarter, alongside increased revenues, suggests a potential improvement in operational efficiency. The company's financial performance exhibits significant enhancements in both profit margins and earnings per share, reflecting effective management of operating costs and revenue streams. The earnings per share, standing at ₹3.80 for Q3FY25, show a considerable improvement both quarter over quarter and year over year.